Alternate-Day Buprenorphine Administration. Phase I - 3

Clinical trial NCT00000221 · COMPLETED

Trial details

NCT number: NCT00000221
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid-Related Disorders

Start date: 1992-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.